Survival after the Onset of De Novo Donor Specific Anti-HLA Antibodies in a Consecutive Series of "Low-Risk" Renal Transplant Patients

被引：0

作者：

Everly, M. J. ^{[1
,2
]}

Rebellato, L. M. ^{[3
]}

Ozawa, M. ^{[1
,2
]}

Briley, K. P. ^{[3
]}

Catrou, P. G. ^{[3
]}

Bolin, P. ^{[3
]}

Kendrick, W. T. ^{[4
]}

Kendrick, S. A. ^{[4
]}

Haisch, C. E. ^{[3
]}

Harland, R. C. ^{[3
]}

Terasaki, P. I. ^{[1
]}

机构：

[1] Terasaki Fdn, Los Angeles, CA USA

[2] One Lambda Inc, Los Angeles, CA USA

[3] E Carolina Univ, Brody Sch Med, Greenville, NC USA

[4] Eastern Nephrol & Associates, Greenville, NC USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

180

引用

页码：80 / 80

页数：1

共 50 条

[41] Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant Patients
Del Bello, A.
Congy-Jolivet, N.
Muscari, F.
Lavayssiere, L.
Esposito, L.
Cardeau-Desangles, I.
Guitard, J.
Doerr, G.
Suc, B.
Duffas, J. P.
Alric, L.
Bureau, C.
Danjoux, M.
Guilbeau-Frugier, C.
Blancher, A.
Rostaing, L.
Kamar, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (04) : 867 - 875
[42] Impact of Anti-HLA Donor Specific Antibodies (DSA) in the Survival and Function of Renal Graft.
de Carvalho, L.
Machado, O.
Seelig, D.
Michelon, T.
dos Santos, A.
Goldani, J.
Garcia, V.
Neumann, J.
Bruno, R.
Keitel, E.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 327 - 327
[43] The Fate of Pre-Transplant Donor-Specific Anti-HLA Antibodies after Transplantation
Marfo, K.
Ling, M.
Greenstein, S.
Chapochnick-Friedmann, J.
Glicklich, D.
Kayler, L.
de Boccardo, G.
Kinkhabwala, M.
Akalin, E.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 234 - 234
[44] Incidence and Impact of De Novo Donor-Specific Anti-HLA Antibodies in ABO-Compatible Liver-Transplant Recipients
Del Bello, A.
Congy-Jolivet, N.
Milongo, D.
Guilbeau-Frugier, C.
Lavayssiere, L.
Muscari, F.
Rostaing, L.
Kamar, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[45] Clinical implication of non-complement-binding de novo donor-specific anti-HLA antibodies in heart transplant recipients
Sato, Takuma
Seguchi, Osamu
Nakajima, Seiko
Matsuda, Sachi
Kanaumi, Yoshiaki
Wada, Kyoichi
Yanase, Masanobu
Ueda, Hatsue
Fukushima, Norihide
Nakatani, Takeshi
TRANSPLANTATION, 2016, 100 (07) : S825 - S825
[46] DE NOVO DONOR SPECIFIC ANTIBODIES AND RENAL GRAFT SURVIVAL
Tarassi, Katerina
Kitsiou, Vasiliki
Athanassiades, Theofilos
Kouniaki, Diamanto
Psarra, Katerina
Koukoulaki, Maria
Apostolou, Theofanis
Drakopoulos, Spiros
Papasteriades, Chryssa
TISSUE ANTIGENS, 2014, 84 (01): : 94 - 94
[47] IMPACT OF EARLY BLOOD TRANSFUSION AFTER KIDNEY TRANSPLANTATION ON THE INCIDENCE OF DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES
Saito, Mitsuru
Satoh, Shigeru
Saito, Takuro
Yamamoto, Ryohei
Nara, Taketoshi
Chiba, Syuji
Kanda, Sohei
Numakura, Kazuyuki
Narita, Shintaro
Inoue, Takamitsu
Habuchi, Tomonori
JOURNAL OF UROLOGY, 2019, 201 (04): : E1043 - E1043
[48] DOES THE OCCURENCE OF POSTTRANSPLANT DE NOVO DONOR-SPECIFIC HLA ANTIBODIES DEPEND ON THE IMMUNOSUPPRESSIVE REGIMEN IN IMMUNOLOGICALLY LOW-RISK PATIENTS?
Sommerer, C.
Morath, C.
Gombos, P.
Schaier, M.
Schwenger, V.
Zeier, M.
Suesal, C.
TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3
[49] Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen
Zecher, Daniel
Bach, Christian
Staudner, Christoph
Boeger, Carsten A.
Bergler, Tobias
Banas, Bernhard
Spriewald, Bernd M.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (04) : 730 - 737
[50] Microcirculation Injury Associates with Donor-Specific Anti-HLA Antibodies in ABO Incompatible Renal Transplant Patients.
de Kort, H.
Charif, R.
Brookes, P.
Kanigicherla, D.
Santos-Nunez, E.
McLean, A.
Taube, D.
Cook, H.
Galliford, J.
Roufosse, C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 333 - 333

← 1 2 3 4 5 →